Fiduciary Alliance LLC Increases Position in Intuitive Surgical, Inc. $ISRG

Key Points

• Fiduciary Alliance LLC increased its position in Intuitive Surgical, Inc. by 8.7%, owning 15,112 shares valued at approximately $8.2 million as of the latest SEC filing.
• Several institutional investors, including Norway Savings Bank and Focus Partners Wealth, significantly increased their holdings in Intuitive Surgical, which now has over 83% owned by institutional investors and hedge funds.
• Intuitive Surgical's stock has received a consensus rating of "Moderate Buy" from analysts, with an average price target of $595.95 after recent target upgrades from multiple research firms.

Fiduciary Alliance LLC increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 8.7% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 15,112 shares of the medical equipment provider's stock after purchasing an additional 1,205 shares during the quarter. Fiduciary Alliance LLC's holdings in Intuitive Surgical were worth $8,212,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of ISRG. Norway Savings Bank increased its holdings in Intuitive Surgical by 53.4% in the 2nd quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider's stock worth $1,420,000 after acquiring an additional 910 shares in the last quarter. Castleark Management LLC lifted its holdings in Intuitive Surgical by 3.4% during the fourth quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock valued at $47,221,000 after purchasing an additional 2,990 shares in the last quarter. Neville Rodie & Shaw Inc. grew its position in shares of Intuitive Surgical by 11.9% in the second quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider's stock valued at $5,666,000 after purchasing an additional 1,110 shares during the period. Arlington Trust Co LLC increased its stake in shares of Intuitive Surgical by 34.5% during the first quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider's stock worth $369,000 after purchasing an additional 191 shares in the last quarter. Finally, Focus Partners Wealth increased its stake in shares of Intuitive Surgical by 49.5% during the first quarter. Focus Partners Wealth now owns 79,306 shares of the medical equipment provider's stock worth $39,278,000 after purchasing an additional 26,270 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

ISRG has been the topic of several research analyst reports. UBS Group lifted their price objective on Intuitive Surgical from $547.00 to $585.00 and gave the stock a "neutral" rating in a report on Wednesday, July 23rd. Wells Fargo & Company raised their target price on Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a research report on Wednesday, July 23rd. Truist Financial boosted their price target on Intuitive Surgical from $590.00 to $600.00 and gave the stock a "buy" rating in a research report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft reissued a "sell" rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Finally, Zacks Research cut shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, August 20th. Thirteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $595.95.

Insider Buying and Selling

In related news, Director Amy L. Ladd sold 336 shares of the firm's stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the transaction, the director directly owned 1,074 shares in the company, valued at $504,898.14. This trade represents a 23.83% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Gary S. Guthart sold 29,360 shares of the business's stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the sale, the insider owned 19,827 shares in the company, valued at $9,368,059.23. This trade represents a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 45,224 shares of company stock valued at $21,716,492. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $433.99 on Tuesday. The company's 50 day simple moving average is $483.65 and its 200-day simple moving average is $506.85. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The company has a market capitalization of $155.58 billion, a price-to-earnings ratio of 60.53, a price-to-earnings-growth ratio of 4.71 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter last year, the firm earned $1.78 EPS. The firm's revenue for the quarter was up 21.4% on a year-over-year basis. Equities analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.